Get the Stockscreener App
65.04
1.88%
-0.96
Neurogene Inc stock is traded at $65.04, with a volume of 237.58K.
It is down -1.88% in the last 24 hours and up +33.28% over the past month.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
See More
Previous Close:
$66.00
Open:
$65.44
24h Volume:
237.58K
Relative Volume:
1.94
Market Cap:
$857.58M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+43.43%
1M Performance:
+33.28%
6M Performance:
+76.79%
1Y Performance:
+0.00%
1-Day Range:
$55.88
$65.64
1-Week Range:
$42.23
$73.59
52-Week Range:
$15.19
$73.59
Neurogene Inc Stock (NGNE) Company Profile
Name
Neurogene Inc
Sector
Industry
Phone
(877) 237-5020
Address
535 W 24TH STREET, NEW YORK
Neurogene Inc Stock (NGNE) Latest News
Neurogene Secures $200M for Genetic Therapy Development - Yahoo Finance
Neurogene Announces Oversubscribed $200 Million Private Placement - BioSpace
Neurogene Reaches 52-Week High on $200M Private Placement - MarketWatch
U.S. stock market: Glatfelter soars 1,106.32%, Nuwellis jumps 114.71%, and Staffing 360 Solutions rises 72.94% in significant midday market gains - Business Upturn
Neurogene secures $200 million in oversubscribed PIPE financing By Investing.com - Investing.com South Africa
Neurogene secures $200M ahead of anticipated study readout - BioPharma Dive
Neurogene (NASDAQ:NGNE) Hits New 1-Year HighHere's Why - MarketBeat
Neurogene secures $200 million in oversubscribed PIPE financing - Investing.com
Neurogene Inc. announced that it expects to receive $199.999935 million in funding from a group of investors - Marketscreener.com
Neurogene (NASDAQ:NGNE) Trading Down 3.7%Here's What Happened - MarketBeat
Short Interest in Neurogene Inc. (NASDAQ:NGNE) Drops By 50.8% - MarketBeat
Analysts Set Neurogene Inc. (NASDAQ:NGNE) PT at $51.00 - MarketBeat
Neurogene (NASDAQ:NGNE) Stock Price Down 4.4%Time to Sell? - MarketBeat
Neurogene to Present Interim Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome - Business Wire
Neurogene (NASDAQ:NGNE) Hits New 12-Month HighWhat's Next? - MarketBeat
Neurogene stock holds steady from BMO Capital By Investing.com - Investing.com UK
Marshall Wace LLP Purchases 11,229 Shares of Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
Neurogene (NASDAQ:NGNE) Trading Up 4.2% - MarketBeat
Renaissance Technologies LLC Has $1.92 Million Position in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Neurogene (NASDAQ:NGNE) Stock Price Down 3.4% - MarketBeat
Neurogene (NASDAQ:NGNE) Sees Unusually-High Trading Volume - MarketBeat
Neurogene's SWOT analysis: gene therapy stock shows promise amid risks - Investing.com
Driehaus Capital Management LLC Has $3.72 Million Stock Holdings in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
Neurogene's SWOT analysis: gene therapy stock shows promise amid risks By Investing.com - Investing.com UK
Neurogene Inc. (NASDAQ:NGNE) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Rhumbline Advisers Invests $491,000 in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
Neurogene (NASDAQ:NGNE) Trading Up 8.2% - MarketBeat
Closing Bell Recap: Neurocrine Biosciences, Inc. (NBIX) Ends at 116.49, Reflecting a -1.07 Downturn - The Dwinnex
Nebius to invest more than USD 1 billion to build AI infrastructure in Europe - sharewise
Renaissance Technologies LLC Raises Holdings in N-able, Inc. (NYSE:NABL) - Defense World
XTX Topco Ltd Sells 4,464 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Defense World
Rhumbline Advisers Has $721,000 Stock Holdings in NETGEAR, Inc. (NASDAQ:NTGR) - Defense World
Raffles Associates LP Has $3.36 Million Holdings in NB Bancorp, Inc. (NASDAQ:NBBK) - Defense World
BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING - WV News
NetApp, Inc. (NASDAQ:NTAP) Shares Sold by American Century Companies Inc. - Defense World
Integral Health Asset Management LLC Buys New Shares in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
70,000 Shares in Neurogene Inc. (NASDAQ:NGNE) Purchased by Integral Health Asset Management LLC - Defense World
NTAP (Netapp Inc) may reap gains as insiders became active recently - Knox Daily
1832 Asset Management L.P. Increases Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Defense World
Ensign Peak Advisors Inc Increases Holdings in NetApp, Inc. (NASDAQ:NTAP) - Defense World
Avoro Capital Advisors LLC Makes New Investment in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Hollencrest Capital Management Buys New Stake in NetApp, Inc. (NASDAQ:NTAP) - Defense World
NetApp, Inc. (NASDAQ:NTAP) Shares Sold by Amalgamated Bank - Defense World
Bank of New York Mellon Corp Purchases New Stake in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Bank of New York Mellon Corp Takes $1.11 Million Position in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
(NBIX) Trading Advice - Stock Traders Daily
Promethos Capital LLC Invests $107,000 in NetApp, Inc. (NASDAQ:NTAP) - Defense World
10,295 Shares in Neuberger Berman Next Generation Connectivity Fund Inc. (NYSE:NBXG) Purchased by Carolinas Wealth Consulting LLC - Defense World
2,056 Shares in NetApp, Inc. (NASDAQ:NTAP) Purchased by Waterloo Capital L.P. - Defense World
Quest Partners LLC Invests $55,000 in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Neurogene (NASDAQ:NGNE) Stock Price Up 4.8% - MarketBeat
Neurogene Inc Stock (NGNE) Financials Data
There is no financial data for Neurogene Inc (NGNE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):